Company Overview and News
As the pace of improvement in fuel economy required by governments around the world have been picking up since 2015, China's new energy car mandatory production system and the US Zero Emission Vehicle (ZEV) program are practically forcing automakers to boost the sales of electric vehicles such as battery electric vehicles (BEVS) and plug-in electric vehicles (PHEVs). European automakers, which were not as enthusiastic about EVs as others, have also joined the movement toward the electrification of powertrains since the 'Dieselgate' scandal.
Here we are, seven months later, and Tesla's (NASDAQ:TSLA) financial performance deteriorates at an alarming rate. Bearish macro scenarios, always just around the corner since 2011, refuse to play out and Queen TINA and King FOMO remain enthroned. The much anticipated interest rate assault by central banks is further delayed. And once it arrives, it will do so in rather piecemeal fashion, unlike the infamous macro-scaremongers suspect.
Global EV sales - September 2017 electric car sales break the best ever record for global sales.
The following slide deck was published by Samsung SDI Co. Ltd. ADR in conjunction with their 2017 Q3 earnings call.
Geely is assembling the building blocks of a global auto empire with EVs at its core.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
The varying economics of the EV supply chain segments point to the raw material supply and battery recycling segments being worth further consideration.
FRANKFURT (Reuters) - Global sales of industrial robots rose by 16 percent in 2016, driven by the electronics industry, and are expected to rise faster in 2017, the International Federation of Robotics (IFR) said on Wednesday.
Samsung, the world's leading smartphone maker, and Apple have pursued divergent strategies since the "patent wars" earlier in the decade.
Investors are betting on a surge in electric car sales after indications that China, the world's largest market for the vehicles, may soon wind down production and sales of cars using fossil fuel.
SGIP reopens in California and Hawaiian market positioned for growth in 2018 as grid-supply option set to close.
Battery partners AES and Siemens cite a projection of rapid growth in the grid-connected battery market.
But it’s a great time to be selling junk bonds. Investors are scooping them up with little regard for the dangers.
SANTIAGO (Reuters) - The Chilean government has short-listed seven companies to develop value-added lithium projects in the country, state development agency CORFO said on Tuesday, the latest move in Chile's push to diversify its exports.
German executives are preparing to announce a new home for a lithium-ion battery plant designed to rival the output at Tesla Inc.’s Gigafactory.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET